X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CYTOTHERAPY

期刊標題檢索 CYTOTHERAPY 最新評論: How many days approximately until a reply? (2023-10-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CYTOTHERAPY]您好,您是該頁面的第 32105 位訪客。

期刊簡介
期刊名稱CYTOTHERAPY CYTOTHERAPY
LetPub Score
7.3
50 ratings
Rate

Reputation
8.7

Influence
6.3

Speed
7.0

期刊簡稱CYTOTHERAPY
ISSN1465-3249
E-ISSN1477-2566
h-index76
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.301.0840.787
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Transplantation
Q114 / 54
Category: Medicine
Subcategory: Oncology
Q2116 / 404
Category: Medicine
Subcategory: Genetics (clinical)
Q235 / 99
Category: Medicine
Subcategory: Immunology and Allergy
Q291 / 233
Category: Medicine
Subcategory: Cancer Research
Q296 / 230
Category: Medicine
Subcategory: Immunology
Q2108 / 236
Category: Medicine
Subcategory: Cell Biology
Q3151 / 285

自引率 (2023-2024)8.10%自引率趨勢
掲載範囲
The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.
官方網站http://informahealthcare.com/loi/cyt
在線稿件提交https://www.editorialmanager.com/JCYT
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區NORWAY
發行頻率隔月刊行
創刊年1999
每年文章數134每年文章數趨勢
黃金OA百分比33.33%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ254/174
CELL & TISSUE ENGINEERINGSCIEQ215/31
CELL BIOLOGYSCIEQ299/205
HEMATOLOGYSCIEQ123/97
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ269/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-3249%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CYTOTHERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    NATURE BIOTECHNOLOGYH-index: 399

    CiteScore: 63.00
    TRENDS IN BIOTECHNOLOGYH-index: 195

    CiteScore: 28.60
    BIOTECHNOLOGY ADVANCESH-index: 161

    CiteScore: 25.50
    MOLECULAR THERAPYH-index: 158

    CiteScore: 19.20
    PLANT BIOTECHNOLOGY JOURNALH-index: 96

    CiteScore: 20.50
    CRITICAL REVIEWS IN BIOTECHNOLOGYH-index: 79

    CiteScore: 20.80
    METABOLIC ENGINEERINGH-index: 101

    CiteScore: 15.60
    Biotechnology for BiofuelsH-index: 75

    CiteScore: 15.70
    CANCER GENE THERAPYH-index: 80

    CiteScore: 10.20
    學科內最受檢索的期刊 頁面查看次數
    BMC GENOMICS434473
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY409579
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY363739
    PLANT BIOTECHNOLOGY JOURNAL237468
    NATURE BIOTECHNOLOGY183736
    BIOTECHNOLOGY AND BIOENGINEERING173560
    GENOMICS168047
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY164056
    BIOTECHNOLOGY ADVANCES156151
    Biotechnology for Biofuels150327
  •  

    CYTOTHERAPY CYTOTHERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [CYTOTHERAPY] 的評論撰寫評論
作者: 岭南睿聪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-01 18:20:58 評論於
How many days approximately until a reply?
(0) 讚! | 岭南睿聪

作者: 岭南睿聪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-01 16:40:07 評論於
Which email is it?
(0) 讚! | 岭南睿聪

作者: sci_中中中


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-07 12:11:52 評論於
The official website address is now https://www.sciencedirect.com/journal/cytotherapy.
(0) 讚! | sci_中中中

作者: 北国振平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-07 09:59:19 評論於
Research focus: Stem cells; Sharing experience of stem cell therapy: Soon, seven days rejected
(0) 讚! | 北国振平

作者: 北国振平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 22:55:50 評論於
Research emphasis: Experience sharing in stem cell therapy. How long does the first review take? Urgent! I need to graduate soon
(0) 讚! | 北国振平

作者: 白云霞绮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-26 12:55:09 評論於
Hello, how is your article coming along? Do all authors need to confirm before submitting for review?
(0) 讚! | 白云霞绮

作者: 金山雯华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-25 09:31:21 評論於
Taylor has a magazine of the same name, but the correct one is in Eastville
(0) 讚! | 金山雯华

作者: 金山雯华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-11 17:43:10 評論於
The submission link here is wrong, the correct link can be found in Esville
(0) 讚! | 金山雯华

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:07:24 評論於
Before starting your research, a comprehensive literature search should be conducted, and review articles related to the field should be read
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:27:33 評論於
References should be preferably within the last 5 years, but early papers can be cited for original and foundational research results
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 13:24:12 評論於
Can very old articles be cited in an introduction?
(0) 讚! | 平原文波

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 08:56:09 評論於
How to comprehensively cover important research in the field in the introduction?
(0) 讚! | 魂魄彦露

作者: 天际佑平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-10 14:40:10 評論於
Hello, how are you doing now?
(0) 讚! | 天际佑平

作者: 凌霄翠梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-09 21:37:13 評論於
It's been 11 days since submission, but still no assignment of a manuscript number, waiting
(0) 讚! | 凌霄翠梅

作者: 大力威威


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-23 23:56:58 評論於
Do all authors need to register an account on the system and agree before submitting their submissions?
(0) 讚! | 大力威威

作者: 朝旭公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-20 19:56:40 評論於
Does this journal require a publication fee?
(0) 讚! | 朝旭公子

作者: Elmer Marcellus


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-26 20:04:27 評論於
Hello, I have been unable to find the magazine's email
(0) 讚! | Elmer Marcellus

作者: 碧水雅媚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-16 09:06:38 評論於
We waited for half a month after submitting our manuscript, but still did not receive a submission number. After sending an inquiry letter, we were assigned a submission number the next day, only to receive a rejection immediately. Quite bold, indeed
(0) 讚! | 碧水雅媚

作者: 光明叶丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-29 13:55:37 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: Reviewed within less than a month, with feedback from two reviewers and helpful comments. Accepted within a week after revisions. It's a good journal
(0) 讚! | 光明叶丹

作者: 销魂天赐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-06 15:31:03 評論於
Do you need to submit raw data? Mahā Samantabhadra 2019-01-08 20:28:00 Posted: Submitted on November 27, under review on the 28th, major revisions were requested on December 20, the reviewer’s comments were fairly constructive, revised on January 5, and accepted on the 8th. Overall, it is a good journal
(0) 讚! | 销魂天赐

作者: 北岳冷青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-08 17:56:04 評論於
Submitted on November 27th, under review on the 28th, received major revisions on December 20th, the review comments were quite constructive, revised on January 5th, accepted on the 8th. Overall, it is a good journal
(0) 讚! | 北岳冷青

作者: 寒阴癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-18 11:59:29 評論於
Submission success rate: 25.0 Experience sharing: The review comments are very pertinent and meticulous
(0) 讚! | 寒阴癸巳

作者: 神古婉柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-04-04 16:31:33 評論於
Review speed: 2.0 Experience sharing: Recently, I received feedback on my submission, requesting a modification of the reference format. I couldn't find it using EndNote. Can anyone advise on how to edit using EndNote, or suggest another method? Thank you
(0) 讚! | 神古婉柔

作者: Nicholas Minnie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-31 22:32:38 評論於
Review speed: 3.0 | Submission success rate: 25.0
Experience sharing: My first submission to SCI was accepted after two major revisions. The editor's feedback was very constructive and detailed, pointing out some issues with the details that needed to be corrected
(0) 讚! | Nicholas Minnie

作者: 筑阳香巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-01-22 23:41:23 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0
Experience sharing: The review was very professional, with very pertinent questions raised, and the review time was long
(0) 讚! | 筑阳香巧

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [CYTOTHERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*